medi-534
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00345670)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- medi-534
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00686075 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2008 | MedImmune |
| NCT00493285 | Phase 1 | Jul 1, 2007 | MedImmune |
| NCT00345670 | Phase 1 | Jun 1, 2006 | MedImmune |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MedImmune | For profit | 3 | 3 | 2 | 2006 |
1 organizations
Page 1 / 1